Xylazine in Belgium: not individually verified
We have not confirmed that Xylazine specifically is scheduled in Belgium, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.
- What is on record
- Not confirmed. Xylazine is not named in Annexes I to IV of the Royal Decree of 6 September 2017, so it is not a controlled drug on the text checked. What could not be established is its Belgian veterinary status: the AFMPS human and veterinary medicine database routes and the AFMPS veterinary pages were searched, and no accessible Belgian product record stating a current delivery status was located. Its veterinary use in other countries is not evidence of a Belgian authorisation, and this cell does not treat it as one.
Confirm directly with Belgium’s national drug authority or your own embassy before you rely on anything.
This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
